Macleods Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Macleods Pharmaceuticals

DeciZen not available for IPO

10 Year X-Ray of Macleods Pharmaceuticals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 27.5%26.8%24.2%28.6%24.1%22.4%24.9%32%22.7%23%-
Value Creation
Index
1.00.90.71.00.70.60.81.30.60.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2,8213,4694,0425,1345,5066,0766,5917,0147,4637,8137,463
Sales YoY Gr.-23%16.5%27%7.2%10.4%8.5%6.4%6.4%4.7%-
Adj EPS 7.29.110.615.917.420.829.833.318.52419.5
YoY Gr.-26.4%16.4%50.2%9.3%19.8%43%11.9%-44.5%29.7%-
BVPS (₹) 27.936.546.162.482.1104.8135.170.990.4115.290.4
Adj Net
Profit
4325456359531,0421,2481,7841,9951,1081,4371,167
Cash Flow from Ops. 4225174381,5535717689601,2751,4112,001-
Debt/CF from Ops. 0.20.30.40000.10.10.10.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 12%7.3%5.8%4.7%
Adj EPS 14.3%6.6%-7%29.7%
BVPS17.1%7%-5.2%27.5%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
29.628.325.629.324.122.324.832.322.923.319
Op. Profit
Mgn %
19.218.719.223.120.922.128.933.420.918.6NAN
Net Profit
Mgn %
15.315.715.718.618.920.527.128.414.818.415.6
Debt to
Equity
0.10.10.10000000-
Working Cap
Days
1331521651351371582352371941980
Cash Conv.
Cycle
5439352932475473100820

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Macleods Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 19.5 0
TTM Sales (₹ Cr.) 7,463 0
BVPS (₹.) 90.4 1
Reserves (₹ Cr.) 5,353 -
P/BV 0.00 0.00
PE 0.00 0.00
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 59.9
Face Value (₹) 1
Industry PE 48

Management X-Ray of Macleods Pharmaceuticals:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Macleods Pharmaceuticals

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales2,820.593,469.014,042.465,134.445,505.516,076.166,590.507,014.117,462.677,813.30
Operating Expenses 2,279.952,821.593,268.543,948.684,352.504,736.764,686.174,670.545,903.286,381.99
Manufacturing Costs201.75258.70335.46334.08494.67608.20252.76398.54439.47434.36
Material Costs1,294.381,596.731,727.322,141.622,308.302,520.512,193.242,179.302,806.082,919.51
Employee Cost 345.81425.87533.46644.46784.40851.911,129.561,149.031,497.481,578.14
Other Costs 438.01540.29672.30828.53765.12756.141,110.62943.671,160.261,449.98
Operating Profit 540.64647.42773.921,185.751,1531,339.401,904.322,343.561,559.381,431.31
Operating Profit Margin (%) 19.2%18.7%19.1%23.1%20.9%22.0%28.9%33.4%20.9%18.3%
Other Income 75.8790.70117.96106.8678.78223.12329.95544.64125.82213.34
Interest 2.493.477.755.794.338.2719.155.8410.817.43
Depreciation 36.0240.6952.6270.0780.7790.2194.63132.13156.55169.85
Exceptional Items 0000000000
Profit Before Tax 578693.96831.511,216.751,146.691,464.042,120.502,750.231,517.841,467.37
Tax 134.17148.33185.24259.8377.58182.32265.26533.91350.61-8.02
Profit After Tax 443.83545.62646.27956.931,069.111,281.731,855.242,216.331,167.231,475.39
PAT Margin (%) 15.7%15.7%16.0%18.6%19.4%21.1%28.2%31.6%15.6%18.9%
Adjusted EPS (₹)7.49.110.816.017.921.431.037.019.524.6
Dividend Payout Ratio (%)5%4%9%0%0%2%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 1,668.612,187.202,761.393,737.704,914.646,277.338,092.694,246.655,413.266,900.18
Share Capital 19.9619.9619.9619.9619.9619.9619.9619.9659.8859.88
Reserves 1,648.652,167.242,741.433,717.744,894.686,257.378,072.734,226.695,353.386,840.29
Minority Interest0000000000
Debt86.71150.561857.687.68067.8979.7278.15127.28
Long Term Debt1.951.957.687.687.68031.82000
Short Term Debt84.76148.61177.3100036.0779.7278.15127.28
Trade Payables260.80380.50498.16782.18655.44492.29690.02522.88536.69592.31
Others Liabilities 315.99237.38224.30328.21483.56604.14545.87469.71411.85274.69
Total Liabilities 2,332.102,955.643,668.844,855.776,061.347,373.779,396.475,318.966,439.947,894.45

Fixed Assets

Gross Block583.04730.781,127.011,379.701,455.081,549.141,804.502,250.052,462.402,716.03
Accumulated Depreciation155.56199.07248.10315.61391.85474.70559.02850.41988.991,097.04
Net Fixed Assets427.48531.71878.911,064.101,063.231,074.441,245.481,399.641,473.421,618.99
CWIP 74.17202104.2114.5926.8351.15213.55252.75334.34189.93
Investments 10.2810.3010.091,321.372,355.241,424.401,841.0416.93252.311,885.65
Inventories393.58483.72592.49789.11710.92720.99895.941,229.591,542.681,239.23
Trade Receivables343.85350.12564.47625.18780.50960.291,198.981,455.301,259.951,126.32
Cash Equivalents 502.38476.12757.27585.25328.591,843.60585.0827.7917.7547.11
Others Assets580.36901.68761.39456.18796.031,298.903,416.40936.971,559.501,787.22
Total Assets 2,332.102,955.643,668.844,855.776,061.347,373.779,396.475,318.966,439.947,894.45

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 422.21517.49437.521,553.12570.56768.25960.181,275.391,411.252,001.06
PBT 578693.96831.511,216.751,146.691,464.042,120.502,750.231,517.841,467.37
Adjustment -7.80-30.19-29.2894.4447.18-97.81-117.42-343113.0598.35
Changes in Working Capital -27.833.27-174.84502.07-374.86-214.9-690.96-654.395.14664.11
Tax Paid 00-189.86-260.15-248.46-383.09-351.93-477.54-314.77-228.77
Cash Flow From Investing Activity -270.49-580.77-111-1,344.46-839.01-747.57-661.95-1,329.57-1,399.59-2,077.32
Capex -165.50-276.67-301.70-1,442.22-102.35-125.55-445.86-785.95-273.20-182.32
Net Investments -0.39-0.0200-893.721,035.79-480.62-914.75-12.46-222.63
Others -104.60-304.08190.7097.76157.06-1,657.81264.53371.13-1,113.92-1,672.37
Cash Flow From Financing Activity -91.3137.02-45.37-5.79-4.33-40.02-115.5130.46-21.1295.36
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 00000-7.680000
Interest Paid -2.49-3.47-7.750-4.33-8.27-16.68-3.12-8.354.95
Dividend Paid -19.96-19.96-72.0700-19.960000
Others -68.8760.4534.45-5.790-4.10-98.8433.58-12.7790.41
Net Cash Flow 60.40-26.26281.15202.87-272.78-19.34182.71-23.72-9.4619.10
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)30.4328.326.1229.4524.7122.925.8235.9224.1723.96
ROCE (%)36.7934.0831.7736.5426.5626.2929.6444.1431.1423.56
Asset Turnover Ratio1.421.341.221.21.010.910.790.951.271.09
PAT to CFO Conversion(x)0.950.950.681.620.530.60.520.581.211.36
Working Capital Days
Receivable Days40364142465260696656
Inventory Days47454949494345556865
Payable Days57739310911483981026971

Macleods Pharmaceuticals Ltd Stock News

Macleods Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Macleods Pharmaceuticals on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Macleods Pharmaceuticals stood at ₹0.00.
The latest P/E ratio of Macleods Pharmaceuticals as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Macleods Pharmaceuticals as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Macleods Pharmaceuticals is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Macleods Pharmaceuticals is ₹7,463 ( Cr.) .

About Macleods Pharmaceuticals Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.